About Conference

Conference Series LLC Ltd invites worldwide global audience and presenters to participate at the Worldwide Forum on Alzheimer and Dementia which is to be held in New York, USA during June 21-22, 2022. Special interest and theme of the conference is “Future of Dementia & Alzheimer: Innovations and Research Outlook”. This event will cover prompt keynote presentations, Oral talks, Poster and presentations.

Dementia 2021 aims to sharing new ideas and technologies amongst the professionals, industrialists, and students from research areas of Psychology, academic scientists, professors, and Research. As the premier event, we have built a program with your interests in mind. We have not only just expanded the number of chances for you to coordinate with associates from over the world yet additionally presented more engaged meetings that will highlight forefront introductions, special panel discussions, and livelier cooperation with industry pioneers, and specialists. Dementia 2021 is a remarkable event intended for International therapeutic well-being experts to encourage the utilization of research discoveries.

Neurological disorders are diseases of the brain, spine and the nerves that connect them. There is ample evidence that pinpoints neurological disorders as one of the greatest threats to public health. There are more than 600 diseases of the nervous system, such as Alzheimer's disease, Brain tumors, Epilepsy, Parkinson's disease, and Stroke, Dementia as well as less familiar ones such as front temporal dementia.

National Alliance provided fund of $650 million to fuel the research on mental illness. NARSAD Young Investigator Grant provides $30,000 per year on research in Neural and behavior disorders such as dementia, schizophrenia, mood disorders, anxiety disorders, or child and adolescent mental illnesses. Brain tumor research receives less than 1% (0.7%) of national cancer research spending in the UK.

In order to accelerate the research in the field of Neuroscience Conference Series organizes different conference series worldwide.

About Organization

• 3000+ Global Events

• 25 Million+ Visitors

• 25000+ unique visitors per conference

• 70000+ page views for every individual conference

• Unique Opportunity! Online visibility to the Speakers and Experts

Why to attend ?

Dementia 2021 will provide an opportunity for all stakeholders working on Alzheimer’s disease and Dementia to talk about novel research. Dementia event can assemble notable speakers, neurologist’s and Dementia researchers from both academia and health care industry will join together to discuss their views and research. The conference will be comprised of sessions by world category specialists in the field of neurology. In dementia on-stream meet 2021, international symposiums, B2B conferences, international workshops will be organized to debate the particular topics within the field of dementia and Alzheimer’s disease.

The benefits provided to the attendees are:

• CME accreditation certificates will be provided to all speakers, delegates and students

• Opportunity to meet the world’s renowned speakers at this event

• Keynote forums by Prominent Physicians & Professors

• Oral/Poster presentations by Young Researchers

• Best poster award for students

• Networking Opportunities

• Grow Your Professional Network

• Build Your Knowledge Base

• Expand Your Resources

• Meet Experts & Influencers Face to Face

• Learning In a New Space

• Break Out of Your Comfort Zone

• New Tips & Tactics

• Greater Focus

• The Serendipity of the Random Workshop

Who should sponsor/exhibit

• Pharmaceuticals

• Drug Manufacturers

• Hospitals

• Educational Institutes

• Research Centers

• Associations

• Societies

• Dementia Care Centers

Target Audience

• Neuroscientist

• Geriatricians

• Neurochemist

• Neurological Surgeon

• Neurologist

• Neuropathology’s

• Neuropharmacologist

• Neurophysiologist

• Neuropsychologist

• Neuroradiology’s

• psychobiologist

• Biological Psychologist

• Psychiatrist

• Neuroscience Nurse

• Psychophysicist

• Professors

• Students

• Neuro drug Manufacturers

Sessions & Tracks

Session 1 on Dementia

Dementia is a syndrome in which deterioration in the memory, thinking and causes other problems in the brain and often gradual decrease in the ability to think and remember that is great enough to affect a person's daily functioning. Other common symptoms include emotional problems, problems with language, and a decrease in motivation. In the early stage of dementia, People with dementia are frequently loses their basic rights and difficult to lead the normal life. The families of affected people also suffer a lot to survive. They face many problems in the society in physical, mental and social pressure. The seven stages of syndrome are,

• No impairment

• Very mild cognitive decline

• Moderate cognitive decline

• Mild cognitive decline

Session 2 on Alzheimer's Disease

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. The most common early symptom is difficulty in remembering recent events short-term memory loss. [As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self-care, and behavioral issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death.

In this session we are able to discuss on medical specialty changes in

• Brain

• Amyloid super molecule,

• Genetic associations

• susceptibleness genes,

• Role of Apo conjugated protein E

• Brain trauma

​Session 3 on Neurology

Neurology is the branch of medicine that deals with the study of nervous system in the brain. If any problem in the axon and the outermost coverings it leads to the loss of data or loss of impulse to other areas. This leads to the loss of memory functions like dementia and Alzheimer. Neurology accompanied with the central nervous system and peripheral nervous system. Peripheral nervous system contains all nerves outside of the nervous system. The departments comes under neurology are,

• Neuro genetics

• Neuropharmacology

• Neuro immunology

• Neuro pediatric

• Neuro psychiatry

​​Session 4 on Parkinson's Diseases

Parkinson's Diseases (PD) is a never-ending and dynamic neurological problems that influence engine work, inflicting bradykinesia, postural unsteadiness, inflexibility and tremor very still. Side effects develop progressively, making start finding troublesome. Parkinson's symptoms commonly begin gradually and get worse over time. As the disease increases, people may have difficulty in walking and talking. The problems are common in people with dementia with Lewy Bodies (LBD) and are often present at the time of diagnosis. Parkinson's disease appears when nerve cells, or neurons, in an area of the brain that controls movement become defective or die.

Other symptoms may include

• Depression

• Other emotional changes

• Difficulty swallowing

• Chewing, and speaking

• Urinary problems or constipation

• Skin problems

• Sleep disruptions

​​​Session 5 on Neurodegenerative Diseases

Neurodegenerative disease is the progressive degeneration of the central nervous system and peripheral nervous system. This progressive degeneration collapses the function and structure of the brain. The common neurodegenerative diseases are Alzheimer’s diseases, Parkinson’s diseases. Neurodegenerative diseases are incurable conditions that result in progressive degeneration of nerve cells. Spinal muscular atrophy is a type of neurodegenerative diseases. In this case the treatment can to prolong the life, it cannot be cured. The symptoms of multiple sclerosis are vision loss, fatigue, pain and impaired coordination.

• Amyotrophic lateral sclerosis

• Aneurysm

• Multiple sclerosis

• Spinal cord injury

​​​​Session 6 on Vascular Dementia

Vascular Dementia is a general term describing the problem based on reasoning, planning, judgement, memory and other thought process caused by the brain from the damaged blood vessels. This disease is mainly happened in the older people with the obesity and diabetes. It is mostly caused at the higher risk of stroke. It mainly affects the heart health, the seven stages of vascular dementia are, memory loss, communication problem, concentration problem, visual perception problem and judgement problem. Alzheimer drugs may help to control cognitive syndrome. Vascular dementia stops the arterial blood flow in the brain. Each person experience different form of dementia based upon their body conditions. On average people with vascular dementia live for around five year after the symptoms begins

• Vascular cognitive impairment

• Neurovascular dysfunction

​​​​​Session 7 on Imaging Techniques for Brain

Imaging techniques play a major role in the detection of dementia diseases. Equipment used for the imaging techniques of dementia are Magnetic Resonance Imaging (MRI) and Computed Tomography (CT). This equipment’s are used for the diagnostic purposes. Both the machine shows the high resolution brain images for diagnostic purposes. MRI fined the loss of brain mass using scanning techniques along with Mild Cognitive Impairment (MCI). MRI can be used to detect the brain tumour, brain injury along with loss of brain mass. It also detects the stroke, multiple sclerosis and dementia. More recently, the researchers quite a few imaging modalities, such as structural and useful Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) studies of cerebral metabolism. Some of the imaging techniques like,

• Magnetic resonance imaging

• Computed tomography

• Positron emission tomography

​Session 8 on Neurological Disorder

Neurological Disorder is the any disorder in the nervous system and causes problems in the brain and the spinal cord. It changes the biochemical actions of the brain cells and leads to variation in the structure. Amyotrophic lateral sclerosis is the progressive neurodegenerative disease that causes defect in the brain cells and the spinal cord. The amyotrophic is comes from Greek language A means No, Myo means Muscle and Trophic means Nourishment, amyotrophic means No Muscle Nourishment. Aneurysm refers to weakening of an artery valve leads to the bulging of valves or distension that further creates the rupturing of artery valves leads to the life threatening conditions. In some cases it doesn’t show any symptoms and it may not cause any dangerous, it suppressed.

• Motor neuron diseases

• Prion diseases

• Schizophrenia

• Autism child

• ADD and ADHD

• Insomnia

Session on 9 Alzheimer’s Clinical Trials and Studies

Clinical preliminaries place unit asked regarding examinations semiconductor diode in individuals to decide whether or not medications sector unit ensured and reasonable. While not clinical investigation and subsequently the help of human volunteers, there may be no higher capsules, no compensatory pastime and no answer for Alzheimer’s grumbling. Clinical preliminaries region unit in some cases implied as scientific examinations; the terms area unit in many cases used equally, in any case their territory unit unnoticeable complexities among them.

• Targeting Amyloid

• Ramping Up the Immune System

• Non-Medication Approaches

• Treatment trials

​Session 10 on Clinical Trials & Case Reports in Dementia

The goal of much of the research activity in dementia is to develop interventions for 'treatment' or even 'cure'. The classical bench to bedside paradigm has been disappointing in dementia. Lewy body dementia is a common but frequently under diagnosed cause of dementia often mistaken for the more familiar entity of Alzheimer disease. Clinically the distinction is important, because it can have profound implications for management. The diagnosis of Lewy body dementia has important implications. It is associated with a high incidence of neuroleptic sensitivity, necessitating great caution in the use of these common antipsychotic agents.

• Immunotherapy

• Frontotemporal dementia

• Clinical psychology

Session 11 on Diagnostic Alzheimer’s & Novel Therapeutics

Novel therapeutics is a standout among the most energizing uses of facts making ready frameworks is in diagnostics and treatment. This is not astonishing, given that contamination analysis is in its center a statistics handling assignment that finishes with a choice. In severe infections, the conclusion can be done in singular cells. Doctors cannot analyze Alzheimer's disease until after death, when they are able to nearly inspect the brain beneath a magnifying instrument.

• Diagnostic Alzheimer

• Neuropsychological testing

• Precision Medicine for Alzheimer Disease

• Novel therapeutics strategies for Dementia

• Novel therapeutics molecule

Session 12 on Childhood Trauma and Dementia

New research recommends there may be a solid relationship among initial formative years trauma, for example, that accomplished by means of the stolen ages, and dementia. There is an expansive settlement demonstrating that childhood trauma is fundamentally associated with the development of sorrow. Psychic trauma is any psychological problems that all of sudden overpowers the capability to provide a negligible feeling of health and integrative wholeness, bringing approximately overpowering nervousness or defenselessness, or its danger, and creating a persevering with change inside the psychic organization. Childhood trauma can affect intellectual and physical health into adulthood.

• Childhood Trauma and PTSD Symptoms

• Childhood trauma with cognitive function in healthy adults

• Post-traumatic stress disorder and Alzheimer's disease

• Psychological Disorders

Session 13 on Anxiety & Depression

Apathy, depression and anxiety are common conditions experienced by people with dementia. They are known as psychological conditions because they can affect a person’s emotional and mental health. Anxiety is more than just feeling stressed or worried. Anxious feelings are a normal reaction to a situation where a person feels under pressure and usually pass once the stressful situation has passed, or the ‘stressor’ is removed. Depression affects how a person feels about themselves. A person may lose interest in work, hobbies and doing things he or she normally enjoys. Some people may lack energy, have difficulty sleeping or sleep more than usual, while some people feel anxious or irritable and find it hard to concentrate.

Common symptoms are:

• Panic, fear, and uneasiness

• Feelings of panic, doom, or danger

• Sleep problems

• Not being able to stay calm and still

• Cold, sweaty, numb, or tingling hands or feet

• Shortness of breath

• Breathing faster and more quickly than normal (hyperventilation)

• Heart palpitations

Session 14 on Animal Model and Translational Medicines

Animal models are the big trust for the researchers to find the medicine and check with that in the animals like testing mouse. In the animal model only support the Alzheimer diseases and closely connect the front temporal diseases. So mostly do the research in the Alzheimer diseases. Patients with Alzheimer’s illness can show the amyloidopathy and tauopathy. Even though the anatomy of mouse is different than the human, the participant value is added. This has crystal rectifier several corporations to specialize in antibodies that block neurodegeneration in these mouse models.

• Animal models of human psychological feature aging

• Development of latest animal models

• Genetic science of translational models

Session 15 on Drug Development in Dementia

Dementia has only little treatment to control and cure the patient and lots of treatment gone failure. Drug development for the dementia is the tedious one. The first drug was approved in the year 2003 and there is no other approval for the dementia drug development. So the drug development for the dementia is going to be complex. A new research on dementia is going on using the amyloid, tau and neurodegeneration condition in the national institute of aging. The drug discovery mainly focus on the repurposing of the drugs, which means the drug is already used for many other conditions and this medicine is again used for the dementia with some modification in that chemicals. The drugs developed for dementia are

• Gantenerumab

• Solanezumab

​Session 16 on Dementia Rehabilitation and Therapy

The people suffered by dementia losses their past activities and forgot the past enjoyment. Problem with memory loss can make a people more difficult to lead their everyday life. Cognitive rehabilitation is a type of therapy which is used to recover the dementia patient. Physical therapy and rehabilitation services have many benefits to improve the quality of life from the dementia and Alzheimer. This service is helpful to relieve the patient from the disease and improve the quality of life. The physical therapist treatment includes the exercise. Some of the types of rehabilitation therapy include,

• Occupational therapy

• Speech therapy

• Physical therapy

Market analysis

Dementia is a general term that describes a group of symptoms-such as decline in mental capability, judgment, language, complex motor skills, and other intellectual function-caused by brain damage from cerebrovascular, death of the brain's nerve cells, or neurons. Dementia may be caused by a number of factors, such as drug abuse, alcoholism, brain injury, side effects to certain medications, thyroid function abnormalities, vitamin B12 deficiency, etc.

Dementia Drugs Market is valued at USD 15535.2 Million in 2018 and expected to succeed in USD 32662.5 Million by 2025 with the CAGR of 11.20% over the forecast period. Dementia may be a syndrome of loss of cognitive functioning such as; thinking, remembering, and reasoning and behavioural abilities to such an extent that it interferes with a person’s lifestyle and activities. It occurs when the parts of the brain used for learning, memory, deciding and language are damaged or diseased. It’s major impact on memory, thinking, and orientation, comprehension calculation, learning capacity, language and judgment. But the consciousness isn't affected. It’s one among the main reason of disability and dependency of older people globally. In older population, Alzheimer’s disease is that the commonest explanation for a progressive dementia but there are various other factors also which causes the dementia. Counting on the cause, a number of the dementia cases could also be reversible majorly affects people of aged 65 years and above. Currently, there's no curative therapy available for dementia disease. However, drugs for dementia therapy are in pipeline, which are expected to be launched within the near future, successively propelling growth of the dementia drugs market.

Alzheimer Association & Societies around the Globe:

• Albanian Alzheimer Society

• Association de Lucha contra el Mal de Alzheimer

• Foundation Alzheimer Aruba (FAA)

• Alzheimer's Australia

• Alzheimer Austria

• Alzheimer Support Group

• Alzheimer Society of Bangladesh

• Barbados Alzheimer's Association Inc.

• Alzheimer’s and Dementia Association of The Cayman Islands

• Ligue National Alzheimer Liga

• Alzheimer's Family Support Group

• Association Bolivian de Alzheimer y Otras Dementias

• FEBRAZ - Federico Brasilia de Associaçãoes de Alzheimer

• Corporation Alzheimer Chile

• Alzheimer's disease Chinese

• Alzheimer Association & Societies in Canada

• Alzheimer's Australia

​Products manufactured by the industries:

Three drugs are available to treat symptoms in people with Mild to moderate Alzheimer’s disease

• Exelon™ produced by Novartis Pharma Canada Inc.

• Reminyl™ produced by Janssen Ortho Inc

• Aricept™ produced by Pfizer Canada Inc.,​​

Past conference report

Conference series LLC Ltd hosted 14^th World Congress on Advances and Innovations in Dementia, which is held during August 26-27, 2020 at Singapore. The main theme of our conference is "Exploring the Challenges and Excellence in Dementia Research" which covers wide range of critically important sessions. Active participation and generous response was received from the Organizing Committee Members, scientists, researchers, as well as experts from Non-government organizations, and students from diverse groups who made this conference as one of the most successful and productive events.

Dementia congress 2020 is distinguished with the attendance of Editorial Board Members of supported Journals such as Journal of Neurology and Neuro Physiology, Journal of neurology & Neuroscience, Journal of Alzheimer’s Disease & Parkinsonism, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference rewarding and fecund.

With the valuable feedback received from the participants of Dementia congress 2020, Conference Series will be glad to announce its next event i.e. Worldwide Forum on Alzheimer and Dementia scheduled for November 16-17, 2021 at London, UK